New drugs hit the target: with two recently approved drugs and dozens more in the pipeline, hepatitis C treatment will improve over the next decade

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature (London) 2011-06, Vol.474 (7350), p.S5
1. Verfasser:	Schlutter, Jana
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral agents Drug therapy Health aspects Hepatitis C Pharmaceutical industry Product development
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue	7350
container_start_page	S5
container_title	Nature (London)
container_volume	474
creator	Schlutter, Jana
description
format	Article
fullrecord	<record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A259589983</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A259589983</galeid><sourcerecordid>A259589983</sourcerecordid><originalsourceid>FETCH-LOGICAL-g2023-e673c83f547bb8613fef848535f1632888a08870ed1a72964523cc3eba31b913</originalsourceid><addsrcrecordid>eNp10F1LwzAUBuAiCs7pfzjolWglbfqRejeGH4MxQQdeljQ9bSNtWpPMqX_DP2ydXmxQL0IO4XlfONlzRl4QR24QsXjfGRHiM5cwGh06R8a8EEJCLw5GztcC15DrVWmgkhZshWC5LtFew1raCuy6BY0Cla0_gHedbt8w_wtw1U_tJyoDTasRpNrkO9lhLRVeQoUdt9JKA1OwGrlt-p6-t65BNpsq6I_epBS-W8hR8ByPnYOC1wZP_u6xs7y9WU7v3fnD3Ww6mbulT3zqYhRTwWgRBnGWscijBRYsYCENCy-iPmOME8ZigrnHYz-JgtCnQlDMOPWyxKNj5-y3tuQ1plIVrdVcNNKIdOKHSciShNFeuQOqRIWa163CQvbPO_50wItOvqbb6GoA8Z_lGykGW893Ar2x_YeVfGVMOnt63LUX_9vJ8nm62NbfaFyqKQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>New drugs hit the target: with two recently approved drugs and dozens more in the pipeline, hepatitis C treatment will improve over the next decade</title><source>Nature</source><source>SpringerLink Journals - AutoHoldings</source><creator>Schlutter, Jana</creator><creatorcontrib>Schlutter, Jana</creatorcontrib><identifier>ISSN: 0028-0836</identifier><identifier>EISSN: 1476-4687</identifier><language>eng</language><publisher>Nature Publishing Group</publisher><subject>Antiviral agents ; Drug therapy ; Health aspects ; Hepatitis C ; Pharmaceutical industry ; Product development</subject><ispartof>Nature (London), 2011-06, Vol.474 (7350), p.S5</ispartof><rights>COPYRIGHT 2011 Nature Publishing Group</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Schlutter, Jana</creatorcontrib><title>New drugs hit the target: with two recently approved drugs and dozens more in the pipeline, hepatitis C treatment will improve over the next decade</title><title>Nature (London)</title><subject>Antiviral agents</subject><subject>Drug therapy</subject><subject>Health aspects</subject><subject>Hepatitis C</subject><subject>Pharmaceutical industry</subject><subject>Product development</subject><issn>0028-0836</issn><issn>1476-4687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp10F1LwzAUBuAiCs7pfzjolWglbfqRejeGH4MxQQdeljQ9bSNtWpPMqX_DP2ydXmxQL0IO4XlfONlzRl4QR24QsXjfGRHiM5cwGh06R8a8EEJCLw5GztcC15DrVWmgkhZshWC5LtFew1raCuy6BY0Cla0_gHedbt8w_wtw1U_tJyoDTasRpNrkO9lhLRVeQoUdt9JKA1OwGrlt-p6-t65BNpsq6I_epBS-W8hR8ByPnYOC1wZP_u6xs7y9WU7v3fnD3Ww6mbulT3zqYhRTwWgRBnGWscijBRYsYCENCy-iPmOME8ZigrnHYz-JgtCnQlDMOPWyxKNj5-y3tuQ1plIVrdVcNNKIdOKHSciShNFeuQOqRIWa163CQvbPO_50wItOvqbb6GoA8Z_lGykGW893Ar2x_YeVfGVMOnt63LUX_9vJ8nm62NbfaFyqKQ</recordid><startdate>20110616</startdate><enddate>20110616</enddate><creator>Schlutter, Jana</creator><general>Nature Publishing Group</general><scope>ATWCN</scope></search><sort><creationdate>20110616</creationdate><title>New drugs hit the target: with two recently approved drugs and dozens more in the pipeline, hepatitis C treatment will improve over the next decade</title><author>Schlutter, Jana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g2023-e673c83f547bb8613fef848535f1632888a08870ed1a72964523cc3eba31b913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Antiviral agents</topic><topic>Drug therapy</topic><topic>Health aspects</topic><topic>Hepatitis C</topic><topic>Pharmaceutical industry</topic><topic>Product development</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schlutter, Jana</creatorcontrib><collection>Gale In Context: Middle School</collection><jtitle>Nature (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schlutter, Jana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New drugs hit the target: with two recently approved drugs and dozens more in the pipeline, hepatitis C treatment will improve over the next decade</atitle><jtitle>Nature (London)</jtitle><date>2011-06-16</date><risdate>2011</risdate><volume>474</volume><issue>7350</issue><spage>S5</spage><pages>S5-</pages><issn>0028-0836</issn><eissn>1476-4687</eissn><pub>Nature Publishing Group</pub><tpages>3</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0028-0836
ispartof	Nature (London), 2011-06, Vol.474 (7350), p.S5
issn	0028-0836 1476-4687
language	eng
recordid	cdi_gale_infotracmisc_A259589983
source	Nature; SpringerLink Journals - AutoHoldings
subjects	Antiviral agents Drug therapy Health aspects Hepatitis C Pharmaceutical industry Product development
title	New drugs hit the target: with two recently approved drugs and dozens more in the pipeline, hepatitis C treatment will improve over the next decade
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T07%3A08%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20drugs%20hit%20the%20target:%20with%20two%20recently%20approved%20drugs%20and%20dozens%20more%20in%20the%20pipeline,%20hepatitis%20C%20treatment%20will%20improve%20over%20the%20next%20decade&rft.jtitle=Nature%20(London)&rft.au=Schlutter,%20Jana&rft.date=2011-06-16&rft.volume=474&rft.issue=7350&rft.spage=S5&rft.pages=S5-&rft.issn=0028-0836&rft.eissn=1476-4687&rft_id=info:doi/&rft_dat=%3Cgale%3EA259589983%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A259589983&rfr_iscdi=true